PURIFICATION OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR FROM THE INCLUSION-BODIES PRODUCED BY TRANSFORMED ESCHERICHIA-COLI-CELLS

被引:28
|
作者
BELEW, M
ZHOU, Y
WANG, S
NYSTROM, LE
JANSON, JC
机构
[1] CHINESE ACAD PREVENT MED,INST VIROL,NATL LAB MOLEC BIOL & GENET ENGN,BEIJING 100052,PEOPLES R CHINA
[2] N CHINA PHARMACEUT CORP,INST ANTIBIOT,HEBEI,PEOPLES R CHINA
关键词
D O I
10.1016/0021-9673(94)80312-9
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF), produced as inclusion bodies in genetically transformed Escherichia coli cells was purified to homogeneity by a three-step chromatographic procedure involving hydrophobic interaction, ion exchange and gel filtration. Each purification step is reproducible and well suited for process-scale operations. The purification process also leads to a significant decrease in DNA and endotoxin levels in the final product. Of the three gel media used, Phenyl Sepharose 6 FF (high sub) was most effective in reducing the DNA content (by a factor of ca. 2000) while Superdex 75 prep grade was more effective for removing endotoxins (reduction factor ca. 15). The recovery of purified rhGM-CSF was 35% by enzyme-linked immunosorbent assay and 70% by a biological assay method. The overall purification factor obtained was about 4.6, which is in the range of those reported for recombinant proteins produced in E. coli as inclusion bodies. The purified rhGM-CSF is an acidic protein (pI = 5.4) and has a specific activity of ca. 3.3.10(7) units/mg, which is in excellent agreement with that reported for its natural counterpart. Its monomer molecular mass of 14 605, as determined by electrospray mass spectrometry, corresponds exactly to the mass calculated from its cDNA sequence. Its amino acid composition and partial NH2-terminal sequence (up to seventeen residues) are also identical with those reported for this protein. These and other results confirm the identity of the purified rhGM-CSF with its natural counterpart. However, the results also showed that it is apparently heterogeneous from its NH2-terminal side as it is composed of three polypeptides having Met, Ala and Pro as the NH2-terminal residues in which the intact Met analogue accounts for 60% for the mixture. This heterogeneity does not seem to have any biological significance since the specific activity of the purified rhGM-CSF is identical with that of its natural counterpart.
引用
收藏
页码:67 / 83
页数:17
相关论文
共 50 条
  • [21] HUMAN RECOMBINANT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PEDIATRIC ONCOLOGY PRACTICE
    FERENCZ, T
    CSAKI, C
    SCHULER, D
    BORSI, JD
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1994, 11 (02) : 201 - 205
  • [22] Pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor: The effects of zidovudine
    Aweeka, FT
    Kwong, M
    Mak, M
    AlUzri, A
    Affrime, M
    Cutler, D
    Kahn, J
    Gambertoglio, JG
    JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 36 (12): : 1107 - 1113
  • [23] Thrombin Stimulates Synthesis of Macrophage Colony-Stimulating Factor, Granulocyte-Macrophage Colony-Stimulating Factor and Granulocyte Colony-Stimulating Factor by Human Proximal Tubular Epithelial Cells in Culture
    Shimaya, Yuko
    Shimada, Michiko
    Shutto, Yoshiko
    Fujita, Takeshi
    Murakami, Reiichi
    Nakamura, Norio
    Yamabe, Hideaki
    Okumura, Ken
    NEPHRON EXTRA, 2012, 2 (01): : 1 - 8
  • [25] A new protocol for solubilization, refolding and purification of recombinant human granulocyte colony-stimulating factor in inclusion bodies
    Liu, Jia Hua
    Wang, Chao Zhan
    Geng, Xin Du
    CHINESE CHEMICAL LETTERS, 2006, 17 (06) : 799 - 802
  • [26] The glycosylation and in vivo stability of human granulocyte-macrophage colony-stimulating factor produced in rice cells
    Kim, Hyoung Jin
    Lee, Dong Hoon
    Kim, Dae Kyong
    Han, Gyu-Bum
    Kim, Hong-Jin
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2008, 31 (02) : 290 - 294
  • [27] Effect of recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor in Shwachman's syndrome
    Vic, P
    Nelken, B
    Mazingue, F
    Gnansounou, M
    Lambilliotte, A
    Turck, D
    INTERNATIONAL JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY, 1996, 3 (06): : 463 - 466
  • [28] Augmentation of human macrophage candidacidal capacity by recombinant human myeloperoxidase and granulocyte-macrophage colony-stimulating factor
    Maródi, L
    Tournay, C
    Káposzta, R
    Johnston, RB
    Moguilevsky, N
    INFECTION AND IMMUNITY, 1998, 66 (06) : 2750 - 2754
  • [29] Recombinant human granulocyte-macrophage colony-stimulating factor as treatment for chronic leg ulcers
    Borbolla-Escoboza, JR
    Maria-Aceves, R
    Lopez-Hernandez, MA
    Collados-Larumbe, MT
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 1997, 49 (06): : 449 - 451
  • [30] Deletion mutants of human granulocyte-macrophage colony-stimulating factor
    Petrovskaya, LE
    Kryukova, EA
    Kayushin, AL
    Rodina, AV
    Moskaleva, EY
    Korobko, VG
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2002, 28 (05) : 397 - 403